198 related articles for article (PubMed ID: 10964095)
1. Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts.
Mallery SR; Pei P; Kang J; Zhu G; Ness GM; Schwendeman SP
Carcinogenesis; 2000 Sep; 21(9):1647-53. PubMed ID: 10964095
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
[TBL] [Abstract][Full Text] [Related]
5. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
Samaniego F; Markham PD; Gallo RC; Ensoli B
J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma.
Lunardi-Iskandar Y; Gill P; Lam VH; Zeman RA; Michaels F; Mann DL; Reitz MS; Kaplan M; Berneman ZN; Carter D
J Natl Cancer Inst; 1995 Jul; 87(13):974-81. PubMed ID: 7629884
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.
Albini A; Fontanini G; Masiello L; Tacchetti C; Bigini D; Luzzi P; Noonan DM; Stetler-Stevenson WG
AIDS; 1994 Sep; 8(9):1237-44. PubMed ID: 7528513
[TBL] [Abstract][Full Text] [Related]
10. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells.
Mallery SR; Pei P; Kang J; Ness GM; Ortiz R; Touhalisky JE; Schwendeman SP
Anticancer Res; 2000; 20(5A):2817-25. PubMed ID: 11062689
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of angiogenic factors in AIDS-related disorders.
Aoki Y; Tosato G
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
[TBL] [Abstract][Full Text] [Related]
13. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
[TBL] [Abstract][Full Text] [Related]
14. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
Thompson EW; Nakamura S; Shima TB; Melchiori A; Martin GR; Salahuddin SZ; Gallo RC; Albini A
Cancer Res; 1991 May; 51(10):2670-6. PubMed ID: 2021945
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo.
Masood R; McGarvey ME; Zheng T; Cai J; Arora N; Smith DL; Sloane N; Gill PS
Blood; 1999 Feb; 93(3):1038-44. PubMed ID: 9920854
[TBL] [Abstract][Full Text] [Related]
16. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex.
Nakamura S; Sakurada S; Salahuddin SZ; Osada Y; Tanaka NG; Sakamoto N; Sekiguchi M; Gallo RC
Science; 1992 Mar; 255(5050):1437-40. PubMed ID: 1371891
[TBL] [Abstract][Full Text] [Related]
19. AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?
Solivetti FM; Elia F; Latini A; Cota C; Cordiali-Fei P; Di Carlo A
J Exp Clin Cancer Res; 2011 Apr; 30(1):40. PubMed ID: 21489270
[TBL] [Abstract][Full Text] [Related]
20. Correlation between AIDS-related Kaposi sarcoma histological grade and in vitro behavior: reduced exogenous growth factor requirements for isolates from high grade lesions.
Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Lantry LE; Blakeslee JR; Stephens RE; Brierley GP
Lymphology; 1995 Sep; 28(3):126-37. PubMed ID: 7475261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
